Literature DB >> 15099407

Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology.

David W Crabb1, Michinaga Matsumoto, David Chang, Min You.   

Abstract

Alcohol dehydrogenase (ADH) and mitochondrial aldehyde dehydrogenase (ALDH2) are responsible for metabolizing the bulk of ethanol consumed as part of the diet and their activities contribute to the rate of ethanol elimination from the blood. They are expressed at highest levels in liver, but at lower levels in many tissues. This pathway probably evolved as a detoxification mechanism for environmental alcohols. However, with the consumption of large amounts of ethanol, the oxidation of ethanol can become a major energy source and, particularly in the liver, interferes with the metabolism of other nutrients. Polymorphic variants of the genes for these enzymes encode enzymes with altered kinetic properties. The pathophysiological effects of these variants may be mediated by accumulation of acetaldehyde; high-activity ADH variants are predicted to increase the rate of acetaldehyde generation, while the low-activity ALDH2 variant is associated with an inability to metabolize this compound. The effects of acetaldehyde may be expressed either in the cells generating it, or by delivery of acetaldehyde to various tissues by the bloodstream or even saliva. Inheritance of the high-activity ADH beta2, encoded by the ADH2*2 gene, and the inactive ALDH2*2 gene product have been conclusively associated with reduced risk of alcoholism. This association is influenced by gene-environment interactions, such as religion and national origin. The variants have also been studied for association with alcoholic liver disease, cancer, fetal alcohol syndrome, CVD, gout, asthma and clearance of xenobiotics. The strongest correlations found to date have been those between the ALDH2*2 allele and cancers of the oro-pharynx and oesophagus. It will be important to replicate other interesting associations between these variants and other cancers and heart disease, and to determine the biochemical mechanisms underlying the associations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15099407     DOI: 10.1079/pns2003327

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  131 in total

Review 1.  Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?

Authors:  Wonhyo Seo; Won-Il Jeong
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

2.  Chronic ethanol exposure alters the lung proteome and leads to mitochondrial dysfunction in alveolar type 2 cells.

Authors:  Abdel A Alli; Elizabeth M Brewer; Darrice S Montgomery; Marcus S Ghant; Douglas C Eaton; Lou Ann Brown; My N Helms
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-03-28       Impact factor: 5.464

3.  A systematic gene-based screen of chr4q22-q32 identifies association of a novel susceptibility gene, DKK2, with the quantitative trait of alcohol dependence symptom counts.

Authors:  Gursharan Kalsi; Po-Hsiu Kuo; Fazil Aliev; Jeffry Alexander; Omari McMichael; Diana G Patterson; Dermot Walsh; Zhongming Zhao; Marc Schuckit; John Nurnberger; Howard Edenberg; John Kramer; Victor Hesselbrock; Jay A Tischfield; Vladimir Vladimirov; Carol A Prescott; Danielle M Dick; Kenneth S Kendler; Brien P Riley
Journal:  Hum Mol Genet       Date:  2010-03-23       Impact factor: 6.150

Review 4.  Novel metals and metal complexes as platforms for cancer therapy.

Authors:  Michael Frezza; Sarmad Hindo; Di Chen; Andrew Davenport; Sara Schmitt; Dajena Tomco; Q Ping Dou
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

5.  Ascertainment bias and the pattern of nucleotide diversity at the human ALDH2 locus in a Japanese population.

Authors:  Benjamin T Brown; August Woerner; Jason A Wilder
Journal:  J Mol Evol       Date:  2007-01-16       Impact factor: 2.395

6.  Placental Proteomics Reveal Insights into Fetal Alcohol Spectrum Disorders.

Authors:  Katie L Davis-Anderson; Sebastian Berger; Emilie R Lunde-Young; Vishal D Naik; Heewon Seo; Greg A Johnson; Hanno Steen; Jayanth Ramadoss
Journal:  Alcohol Clin Exp Res       Date:  2017-08-09       Impact factor: 3.455

7.  Autoantibody against aldehyde dehydrogenase 2 could be a biomarker to monitor progression of Graves' orbitopathy.

Authors:  Kai-Chun Cheng; Yu-Jen Wu; Kai-Hung Cheng; Kai-Yuan Cheng; Kuo-Jen Chen; Wen-Chuan Wu; Po-Yen Lee; Cheng-Hsien Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-03       Impact factor: 3.117

8.  A comparative 90-day toxicity study of allyl acetate, allyl alcohol and acrolein.

Authors:  Scott S Auerbach; Joel Mahler; Gregory S Travlos; Richard D Irwin
Journal:  Toxicology       Date:  2008-09-04       Impact factor: 4.221

9.  Differential blocking effects of the acetaldehyde-derived DNA lesion N2-ethyl-2'-deoxyguanosine on transcription by multisubunit and single subunit RNA polymerases.

Authors:  Tsu-Fan Cheng; Xiaopeng Hu; Averell Gnatt; Philip J Brooks
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

10.  Nicotinic acetylcholine receptors are sensors for ethanol in lung fibroblasts.

Authors:  Jeffrey D Ritzenthaler; Susanne Roser-Page; David M Guidot; Jesse Roman
Journal:  Alcohol Clin Exp Res       Date:  2013-02-19       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.